The present disclosure relates to the field of bio-functionalization of surfaces by nanolithography, for applications in biology, chemistry and more generally biochemistry, involving optical microscopy of the surface.
In the field of nanolithography, document EP2736635, which aims to produce patterns of metal nanoparticles on a substrate, is, for example, known. Typically, the metal nanoparticles are made of gold and the substrate is an inorganic oxide of high optical refractive index (for example, TiO2, ZnO, etc.).
Document U.S. Pat. No. 9,180,519, which describes a process for fabricating nanostructures distributed in a preset pattern with a view to adhering a target thereto, whether this be for optical or biological devices, is also known. The nanostructures are typically gold nanopads.
Other documents are known, for example, US20050046758 and WO2014052759 or even the publication “Nanometric protein-patch arrays on glass and polydimethylsiloxane for cell adhesion studies,” F. Pi et al., Nano Lett. 2013, 13, 3372-3378. However, all these documents make provision to produce metal and, in particular, gold nanostructures (also called nanopads, nanoislands or nanoparticles) allowing the adhesion of proteins.
However, the presence of such metal nanostructures causes problems for optical microscopy, for example, via non-linear optical effects.
The present disclosure allows this problem to be solved.
More precisely, the present disclosure relates to a method for treating a surface of a dielectric slide that is transparent to visible light, with a view to observation of the dielectric slide by optical microscopy.
It comprises the following steps:
Provision may also be made for a step comprising:
Provision may furthermore be made, prior to the functionalizing step, for a step comprising:
Provision may also be made for a step comprising:
Provision may also be made for a step comprising:
Provision may also be made for a step comprising:
Provision may also be made for a step comprising:
Provision may also be made for a step comprising:
Provision may be made for the exposure of the negative film to an electron beam to be carried out at a preset constant temperature.
Provision may be made for the step of depositing the metal film on the surface of the slide to be carried out by evaporation or by sputtering, the thickness of the metal film being smaller than that of the negative film.
By virtue of the present disclosure, the islands of proteins are arranged in a preset pattern the total area of which may be from a few square microns up to 1 mm2 or 2 mm2.
Each island of proteins may have an equivalent diameter as small as 50 nm. The islands may be arranged in an array the pitch of which is as small as 100 nm. Thus, when a biological cell is placed on a carrier slide, it makes contact with a plurality of islands of proteins.
Other features and advantages of the present disclosure will become more clearly apparent on reading the following description, which is given by way of illustrative and non-limiting example, with reference to the appended figures.
Embodiments of the present disclosure comprise treating a surface of a dielectric slide 10 that is transparent to visible light, with a view to the observation by optical microscopy of the dielectric slide 10, which in the present embodiment is a glass slide (
For the sake of conciseness, the dielectric slide 10 that is transparent to visible light, which serves as a carrier, is referred to simply as the “slide” (e.g., slide 10) below.
Provision may optionally be made to uniformly deposit a layer of adhesion promoter 20 on the surface of the slide 10 (
Next, provision is made to deposit, on the slide 10, a negative film 30 comprising a polymerizable composition that polymerizes when it is exposed to an electron beam (
Preferably, the exposure of the negative film 30 to an electron beam is carried out at a preset constant temperature.
The negative film 30 may then be exposed to an electron beam FE (
Each point of contact between the electron beam FE and the negative film 30 allows the composition of the negative film 30 to be polymerized plumb with the point of contact, this creating a cylinder or pad 40 of polymerized composition. For example, the composition is a resist.
Once the preset pattern has been fully drawn, provision is made to develop the negative film 30 in order to dissolve the unpolymerized composition, for example, via immersion in a solvent.
A set of polymerized-resist pads is thus obtained, each pad corresponding to one point of the preset pattern (
Provision may then be made to deposit a metal film (or layer) 50 on the negative film of the surface of the slide (
In the present embodiment, the deposition is carried out by evaporation or sputtering. In the present embodiment, the metal is aluminum.
Preferably, the thickness of the metal film 50 is smaller than that of the negative film 30. In other words, the height of the pads 40 is larger than the thickness of the metal film 50 (
Provision may be made for the ratio between the thickness of the metal film and the thickness of the negative film 30 to be higher than a threshold value.
The resist film 30 may then be dissolved. In the present embodiment, the dissolution is achieved by dipping in a bath of organic solvent suitable for the polymerizable composition. The dissolution of the resist film 30, i.e., of the pads 40, leads to the lift off of the metal film 50 on the pads 40 but not of the metal film 50 between the pads 40. Thus, after dissolution, the metal film 50 on the exterior surface of the slide 10 contains holes 60 where the pads 40 used to be and has a constant thickness elsewhere (
Each hole 60 therefore corresponds to the base of one pad 40.
At this stage, the slide 10 may be stored for several months.
Provision is then made to functionalize the surface of the slide 10 by depositing a layer, a monolayer for example, of functional proteins, for example by incubation in a protein bath, in the holes 60 of the metal film, so as to produce a set of islands 70 of proteins, each island 70 of proteins being placed in a respective hole 60 of the metal film 50 (
In the present embodiment, the monolayer of proteins is a monolayer of bovine serum albumin marked with a label, in the present embodiment biotin (vitamin H).
To this end, provision is preferably made to deposit an adhesion primer (not illustrated) in the holes 60 of the metal film 50 prior to the deposition of a monolayer of proteins, for example by evaporation or by submerging the slide 10 in an aqueous solution.
The adhesion primer is, for example, a molecule, in the present embodiment an aminosilane molecule, that not only allows covalent bonds to be made with the glass of the slide 10 but also allows the adhesion of preset proteins.
Each island 70 of proteins may have an equivalent diameter as small as 50 nm. Depending on the preset pattern chosen, the islands 70 of proteins may be arranged in an array the pitch of which is as small as 100 nm.
Thus, when a biological cell is placed on a carrier slide functionalized according to the present disclosure, it may make contact with a plurality of islands 70 of proteins.
A biological cell in contact with a functionalized slide according to the present disclosure reacts differently not only depending on the pattern (and notably on the equivalent diameter of the islands 70, the density of the islands 70 and the pitch of the array) but also depending on the nature of the proteins of the islands 70. Thus, preferably, all of the islands 70 of proteins comprise the same proteins.
Provision may then be made to dissolve the metal film 50 (
Thus, following the dissolution of the metal film 50, all that remains on the surface of the slide 10 are nanopads of proteins, i.e., the proteins of the islands 70 of proteins, adhering to the surface of the slide 10 directly or via the adhesion promoter 20, i.e., the metal nanostructures that would otherwise interfere with the light of an optical microscope have been removed.
Thus, contrary to the references cited at the start of the description, by virtue of the present disclosure, no metal nanopads remain between the islands 70 of proteins and the surface of the slide 10.
At this stage, the slide 10 may be stored for several days.
Provision may also be made to passivate the surface of the slide 10 between the islands 70 of proteins with a passivation layer 80 (
The functionalization of the surface of the slide 10 may then be finalized by bringing the surface of the slide 10, which is optionally passivated, into contact with a first set of at least one functional protein 90, antibodies for example, capable of reacting with the proteins of the islands 70 of proteins (
The first set of at least one functional protein 90 allows living biological cells brought into contact with the surface of the slide 10 to be studied, notably by optical microscopy.
A functionalized slide 10 according to embodiments of the present disclosure may take the form of a lab-on-a-chip.
At this stage, the slide 10 may be stored for several hours.
The present disclosure is not limited to the embodiments described above.
For example, provision may be made to also functionalize the passivation layer 80 (
To this end, a second set of at least one functional protein 100 may be provided, the proteins of the second set of at least one functional protein 100 being different from the proteins of the first set of at least one functional protein 90 and preferably not being capable of reacting with the proteins of the islands 70 of proteins.
For example, for immune cells (T cells), provision is made for the first set of at least one functional protein 90 to be a receptor and for the second set of at least one functional protein 100 to be a co-receptor.
By virtue of the present disclosure, a plurality of islands 70 of proteins may be manufactured simultaneously.
Number | Date | Country | Kind |
---|---|---|---|
1853414 | Apr 2018 | FR | national |
This application is a national phase entry under 35 U.S.C. § 371 of International Patent Application PCT/FR2019/050915, filed Apr. 17, 2019, designating the United States of America and published as International Patent Publication WO 2019/202260 A2 on Oct. 24, 2019, which claims the benefit under Article 8 of the Patent Cooperation Treaty to French Patent Application Serial No. 1853414, filed Apr. 18, 2018.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/FR2019/050915 | 4/17/2019 | WO | 00 |